Deneen Vojta
Overview
Explore the profile of Deneen Vojta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
661
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vad V, Madrazo-Ibarra A, Estrin D, Pollak J, Carroll K, Vojta D, et al.
BMC Musculoskelet Disord
. 2022 Oct;
23(1):923.
PMID: 36261825
Background: Intervertebral disc pathology is the most common identifiable cause of chronic lower back pain (CLBP). There are limited conservative alternatives to treat discogenic axial CLBP. Back Rx is a...
2.
Ibrahim S, Lowe J, Bramante C, Shah S, Klatt N, Sherwood N, et al.
Front Endocrinol (Lausanne)
. 2021 Aug;
12:587801.
PMID: 34367059
Metformin is the first-line medication for type 2 diabetes, but it also has a long history of improved outcomes in infectious diseases, such as influenza, hepatitis C, and assays of...
3.
OBrien M, Stephen J, Norton K, Meehan T, Vojta D, Ackermann R
Prim Care Diabetes
. 2021 Jul;
15(6):1104-1106.
PMID: 34301495
This pilot trial studied a novel intervention that integrated diabetes technologies into team-based primary care for type 2 diabetes. We found clinically significant reductions in blood pressure, weight, and glucose....
4.
Volerman A, Fierstein J, Boon K, Vojta D, Gupta R
Ann Allergy Asthma Immunol
. 2021 Jun;
127(3):392-394.
PMID: 34098112
No abstract available.
5.
Kan K, Shaunfield S, Kanaley M, Chadha A, Boon K, Foster C, et al.
JMIR Pediatr Parent
. 2021 Apr;
4(2):e25811.
PMID: 33890861
Background: Electronic medication monitoring (EMM) is a digital tool that can be used for tracking daily medication use. Previous studies of EMM in asthma management have been conducted in adults...
6.
Khera R, Clark C, Lu Y, Guo Y, Ren S, Truax B, et al.
J Am Heart Assoc
. 2021 Feb;
10(13):e018086.
PMID: 33624516
Background Despite its clinical significance, the risk of severe infection requiring hospitalization among outpatients with severe acute respiratory syndrome coronavirus 2 infection who receive angiotensin-converting enzyme (ACE) inhibitors and angiotensin...
7.
Bramante C, Buse J, Tamaritz L, Palacio A, Cohen K, Vojta D, et al.
J Med Virol
. 2021 Feb;
93(7):4273-4279.
PMID: 33580540
Observational studies suggest outpatient metformin use is associated with reduced mortality from coronavirus disease-2019 (COVID-19). Metformin is known to decrease interleukin-6 and tumor-necrosis factor-α, which appear to contribute to morbidity...
8.
Bramante C, Ingraham N, Murray T, Marmor S, Hovertsen S, Gronski J, et al.
Lancet Healthy Longev
. 2021 Feb;
2(1):e34-e41.
PMID: 33521772
Background: Type 2 diabetes and obesity, as states of chronic inflammation, are risk factors for severe COVID-19. Metformin has cytokine-reducing and sex-specific immunomodulatory effects. Our aim was to identify whether...
9.
Gupta R, Fierstein J, Boon K, Kanaley M, Bozen A, Kan K, et al.
Pediatrics
. 2021 Jan;
147(1).
PMID: 33386336
Background: Although sensor-based monitoring of daily inhaled corticosteroids (ICSs) and short-acting β-agonist medications may improve asthma outcomes, the effectiveness of these interventions in diverse pediatric populations remains unclear. Methods: Caregiver...
10.
Kan K, Shaunfield S, Kanaley M, Chadha A, Boon K, Morales L, et al.
J Asthma
. 2020 Nov;
59(2):342-351.
PMID: 33198550
Objective: Little is known about the implementation challenges health providers might face with the use of digital health in outpatient asthma care. To qualitatively explore the experience of health providers...